Desmosterol Deposition in Human and Experimental Atherosclerosis
- 1 February 1963
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 12 (2) , 228-234
- https://doi.org/10.1161/01.res.12.2.228
Abstract
The role of desmosterol in the production of atherosclerotic plaques has been studied. By means of gas chromatographic analysis, it has been possible for the first time to show that in patients treated with triparanol, even for short periods of time, desmosterol does contribute to the sterol deposition. Furthermore, in the induced atherosclerotic plaques of rabbits desmosterol has been found to deposit at least as readily as does cholesterol. It is concluded from these observations that the replacement of serum cholesterol with desmosterol does not seem to offer a rational approach to the treatment of atherosclerosis.Keywords
This publication has 7 references indexed in Scilit:
- DEPOSITION OF DESMOSTEROL IN THE LESIONS OF EXPERIMENTAL ATHEROSCLEROSISThe Lancet, 1962
- Gas chromatography of steroids. Relation of structure to molar response in argon ionization detectorAnalytical Chemistry, 1961
- Identification of 24-Dehydrocholesterol in Human Blood Vessels Following MER-29 Therapy.Experimental Biology and Medicine, 1961
- THE DETERMINATION OF THE AREAS OF RESOLVED AND PARTIALLY RESOLVED CHROMATOGRAPHY PEAKSCanadian Journal of Chemistry, 1960
- Gas chromatography of adrenal cortical steroid hormonesBiochemical and Biophysical Research Communications, 1960
- Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesisBiochemical and Biophysical Research Communications, 1960
- Specific inhibition of cholesterol biosynthesis by a synthetic compound (MER-29)Archives of Biochemistry and Biophysics, 1959